Picture of Teleflex logo

TFX Teleflex Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual income statement for Teleflex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
R2023
December 31st
R2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,8102,7911,7121,7001,993
Cost of Revenue
Gross Profit1,5501,5311,0401,0371,121
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses2,1942,2921,4541,5961,874
Operating Profit615499259104118
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes55944618526.324.6
Provision for Income Taxes
Net Income After Taxes48536314457.258.5
Net Income Before Extraordinary Items
Extraordinary Items
Net Income48536335669.7-906
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income48536335669.7-906
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS9.27.923.773.293.31
Dividends per Share